The Federal Hemp Ban Begins: Prohibition on THC-O Products Goes Into Effect, Broader Ban Starts on December 11
The first phase of the federal government’s new restrictions on hemp products took effect on November 12, 2026. Under the new law, hemp-derived products containing cannabinoids that cannot naturally be produced by the cannabis plant are now excluded from the federal definition of legal “hemp.”
This change has immediate consequences for hemp manufacturers, wholesalers, and retailers, particularly those dealing in synthetic cannabinoids such as THC-O, which may now be treated as illegal controlled substances under federal law.
That said, the November 12 deadline does not mean that all synthetic or semi-synthetic cannabinoids are now federally prohibited, at least not yet. Many popular hemp-derived cannabinoids, like Delta-8-THC and THCP, have been identified in the cannabis plant even though the versions sold commercially are frequently manufactured through chemical conversion processes.
That distinction matters because Congress delayed most of the broader federal hemp restrictions until December 11, 2026. Unless Congress intervenes, those restrictions will likely eliminate the federal exemption that much of the nation’s hemp industry currently depends on
As we discussed in our previous coverage of the federal hemp ban and Congress’s September 2026 decision to postpone most of its provisions, the changes are significant because they do not merely establish new regulations for hemp businesses. They redefine which products qualify as hemp under federal law and, consequently, which products are exempt from federal controlled-substance laws.
What Changed on November 12, 2026?
When Congress passed the federal hemp ban in November 2025, most changes were scheduled to become effective one year later, on November 12, 2026.
In September 2026, however, Congress passed Public Law 119-103, postponing most of those changes until December 11.
There was one important exception.
Beginning November 12, intermediate and finished hemp-derived cannabinoid products containing cannabinoids that are “not capable of being naturally produced by a Cannabis sativa L. plant” are excluded from the federal definition of hemp.
The restriction applies both to finished consumer products, such as vape cartridges, gummies, and tinctures, and to intermediate products used by manufacturers to create and infuse hemp-derived cannabinoids like Delta-8-THC, HHC, THCP, and THCV.
Under the federal Controlled Substances Act, hemp and hemp derivatives have been exempted from the laws that prohibit marijuana and THC. Products excluded from the definition of hemp lose that exemption and can be treated as controlled substances.
The important distinction is that the November 12 ban focuses on whether the cannabinoid itself can naturally be produced by the cannabis plant—not whether a manufacturer actually extracted it from a plant. Congress separately addressed naturally occurring cannabinoids manufactured through chemical synthesis, but delayed that restriction until December 11.
THC-O: One Cannabinoid Clearly Affected by the New Law
THC-O, generally referring to Delta-8-THC-O acetate or Delta-9-THC-O acetate, is one of the clearest examples of a cannabinoid affected by the November 12 ban.
THC-O is produced through a chemical process that modifies another form of THC by adding an acetate group. Unlike conventional Delta-9-THC or Delta-8-THC, THC-O has not been established as a naturally occurring cannabinoid in the cannabis plant.
The Drug Enforcement Administration has previously taken the position that THC-O is a Schedule I controlled substance. In a February 13, 2023 opinion letter, DEA concluded that Delta-8-THC-O and Delta-9-THC-O do not occur naturally in cannabis and can only be obtained through synthesis.
That position was not universally accepted under the original 2018 Farm Bill. In Anderson v. Diamondback Investment Group, the Fourth Circuit held in 2024 that the original Farm Bill’s broad definition of hemp could include THC-O derived from hemp, notwithstanding DEA’s contrary interpretation.
The new hemp ban, however, expressly excludes cannabinoids that are not occurring in the cannabis plant. Accordingly, businesses selling THC-O products should treat those products as presenting serious criminal exposure.
What About THCP? The Scientific Evidence Is More Complicated
THCP, or tetrahydrocannabiphorol, presents a different question.
THCP is a relatively uncommon cannabinoid that has gained popularity because of its potency. It is found in vapes, gummies, and other hemp products.
Like Delta-8-THC, THCP is ordinarily present, if at all, in very small amounts in the cannabis plant. The THCP in these products is generally produced using chemical conversion instead of extracting it directly from cannabis plants.
Unlike THC-O, however, there is at least some scientific evidence that THCP naturally occurs in cannabis. In December 2019, a group of Italian researchers led by Cinzia Citti published a study in Scientific Reports identifying Delta-9-THCP in a medicinal cannabis variety. The researchers isolated and characterized the compound, describing it as a naturally occurring phytocannabinoid.
A subsequent 2021 study published in the Journal of Natural Products measured Delta-9-THCP in cannabis inflorescences from multiple cannabis varieties, providing further evidence of its presence in the plant.
Not all researchers agree on how to characterize THCP, particularly when discussing commercially manufactured products. A 2026 scientific review acknowledged studies reporting THCP in cannabis at trace concentrations while questioning whether commercial THCP products are actually extracted from botanical material. The authors suggested that commercially available THCP is likely synthesized rather than extracted.
These findings illustrate an important difference between a cannabinoid’s natural existence and the process used to manufacture it.
Of course, this distinction may become irrelevant after December 11, when the separate restriction on naturally occurring cannabinoids synthesized outside the plant is scheduled to take effect.
Are Delta-8-THC, HHC, and Other Hemp Cannabinoids Now Illegal?
The new federal law, as it is in effect at this time, does not prohibit every cannabinoid merely because it is described as “synthetic.” Delta-8-THC, for example, has been documented as naturally occurring in cannabis, albeit generally in small quantities. Most commercial Delta-8-THC, HHC, and other cannabinoids are produced by converting hemp-derived CBD through chemical processing.
That manufacturing process alone does not necessarily trigger the November 12 exclusion. Whether a particular substance is naturally produced by cannabis may depend on its precise chemical structure and the available scientific literature.
At this time, federal law does not provide a comprehensive list of which cannabinoids satisfy the natural-production test, though Congress directed the Food and Drug Administration to publish lists identifying naturally occurring cannabinoids and related substances. As the Congressional Research Service noted in an October 28, 2026 report, FDA had not yet published those lists.
That leaves businesses and law enforcement agencies without an authoritative federal inventory of which cannabinoids are prohibited under the new provision. The absence of that guidance creates significant uncertainty. But it does not suspend the law or automatically protect businesses from criminal liability.
The Much Broader Federal Hemp Ban Is Still Scheduled for December 11
Although November 12 marks the first significant change, December 11, 2026 remains the more consequential date for the hemp industry.
Unless Congress changes the law again, the remaining restrictions enacted in November 2025 will take effect. Those restrictions will fundamentally change the federal definition of hemp in three ways, as we’ve previously covered:
- Naturally occurring cannabinoids synthesized outside the plant will be excluded.
- The federal hemp standard will change from Delta-9-THC to total THC.
- Finished hemp products will be limited to 0.4 milligrams of THC and similar cannabinoids per container.
What Does This Mean for Criminal Enforcement?
When a product loses its legal status as “hemp,” its manufacture, distribution, and possession may become subject to the Controlled Substances Act, including potential criminal prosecution and forfeiture. The implications are significant for businesses that operate across state lines, manufacture substantial quantities of cannabinoid products, or maintain large inventories.
The enactment of a new federal definition does not guarantee immediate, widespread criminal enforcement. Federal prosecutors and law enforcement agencies will still have to determine which products are covered, establish their chemical composition, and satisfy the elements of any charged offense.
In cases involving disputed cannabinoids such as THCP, there may be substantial disagreement between prosecutors and defense experts concerning whether a cannabinoid is naturally producible by cannabis.
That uncertainty could create important issues concerning statutory interpretation, laboratory testing, and whether the government can prove that a particular product was actually a controlled substance. There may be significant disputes concerning a defendant’s knowledge of the substances being manufactured or sold.
Georgia businesses must also recognize that state law operates independently of the federal changes. Georgia already regulates consumable hemp products through the Georgia Hemp Farming Act and Department of Agriculture regulations. Those laws do not disappear merely because Congress changes federal law.
Conversely, compliance with Georgia’s hemp licensing and testing requirements does not immunize a business from federal controlled-substance laws.
Will Congress Intervene Before December 11?
Congress has the ability to delay, repeal, or modify the federal hemp ban before the remaining provisions take effect. Several proposals have been introduced that would extend the deadline or replace the current restrictions with a comprehensive regulatory framework. For example, the Lawful Hemp Protection Act, H.R. 9830 proposes regulations for hemp products rather than criminal bans.
Unless a new law is enacted, however, the November 12 restrictions remain in force and the broader federal hemp amendments will take effect on December 11.
The Church Law Firm represents businesses and individuals facing hemp and cannabis regulatory investigations, product seizures, forfeiture proceedings, and state and federal criminal charges. Hemp businesses concerned about the effect of these new federal restrictions should seek advice based on their specific products, manufacturing processes, and applicable state laws.